首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: A 13-y prospective population study
【24h】

Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: A 13-y prospective population study

机译:血清25-羟基乙多胺D,死亡率和事件心血管疾病,呼吸系统疾病,癌症和骨折:13岁的预期人口研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: Vitamin D is associated with many health conditions, but optimal blood concentrations are still uncertain. Objectives: We examined the prospective relation between serum 25-hydroxyvitamin D [25(OH)D] concentrations [which comprised 25(OH)D3 and 25(OH)D2] and subsequent mortality by the cause and incident diseases in a prospective population study. Design: Serum vitamin D concentrations were measured in 14,641 men and women aged 42-82 y in 1997-2000 who were living in Norfolk, United Kingdom, and were followed up to 2012. Participants were categorized into 5 groups according to baseline serum concentrations of total 25(OH)D 30, 30 to 50, 50 to 70, 70 to 90, and ≥90 nmol/L. Results: The mean serum total 25(OH)D was 56.6 nmol/L, which consisted predominantly of 25(OH)D3 (mean: 56.2 nmol/L; 99% of total). The age-, sex-, and month-adjusted HRs (95% CIs) for all-cause mortality (2776 deaths) for men and women by increasing vitamin D category were 1, 0.84 (0.74, 0.94), 0.72 (0.63, 0.81), 0.71 (0.62, 0.82), and 0.66 (0.55, 0.79) (P-trend 0.0001). When analyzed as a continuous variable and with additional adjustment for body mass index, smoking, social class, education, physical activity, alcohol intake, plasma vitamin C, history of cardiovascular disease, diabetes, or cancer, HRs for a 20-nmol/L increase in 25(OH)D were 0.92 (0.88, 0.96) (P 0.001) for total mortality, 0.96 (0.93, 0.99) (P = 0.014) (4469 events) for cardiovascular disease, 0.89 (0.85, 0.93) (P 0.0001) (2132 events) for respiratory disease, 0.89 (0.81, 0.98) (P = 0.012) (563 events) for fractures, and 1.02 (0.99, 1.06) (P = 0.21) (3121 events) for incident total cancers. Conclusions: Plasma 25(OH)D concentrations predict subsequent lower 13-y total mortality and incident cardiovascular disease, respiratory disease, and fractures but not total incident cancers. For mortality, lowest risks were in subjects with concentrations 90 nmol/L, and there was no evidence of increased mortality at high concentrations, suggesting that a moderate increase in population mean concentrations may have potential health benefit, but 1% of the population had concentrations 120 nmol/L.
机译:背景:维生素d与许多健康状况有关,但最佳的血药浓度仍不明朗。目标:我们检查了血清25-羟基d之间的预期关系[25(OH)d]浓度[其中包含25(OH)D3和25(OH)D 2]和在前瞻性群体研究由原因并入射疾病后续死亡率。设计:在1997 - 2000年14,641男性和女性,年龄42-82Ÿ谁住在诺福克,英国,测定血清维生素d的浓度,并随访至2012年参加根据基线血清浓度被分为5组总25(OH)d小于30,30到& 50,50到& 70,70到& 90,和≥90nmol / L的。结果:平均血清总25(OH)d为56.6纳摩尔/ L,其由主要的25(OH)D3(平均:56.2纳摩尔/ L;总的99%)。在年龄,性别和每月调整的HR(95%CI)的全因死亡率(2776人死亡),男性和女性增加的维生素d类别分别为1,0.84(0.74,0.94),0.72(0.63,0.81 ),0.71(0.62,0.82),和0.66(0.55,0.79)(P-趋势< 0.0001)。当分析作为连续变量和与身体质量指数,吸烟,社会阶层,教育,体力活动,饮酒,附加的调节血浆维生素C,心血管疾病,糖尿病,或癌症,的历史的HR为20 nmol / L的增加25(OH)d分别为0.92(0.88,0.96)(P< 0.001)为总死亡率,0.96(0.93,0.99)(P = 0.014)(4469个事件),心血管疾病,0.89(0.85,0.93)( P< 0.0001)(2132个事件),呼吸系统疾病,0.89(0.81,0.98)(P = 0.012)(563个事件),骨折,和1.02(0.99,1.06)(P = 0.21)(3121个事件),事件总癌症。结论:等离子体25(OH)d浓度预测随后的较低13-γ总死亡率和入射心血管疾病,呼吸系统疾病,和骨折但不总入射癌症。死亡率,最低风险是与浓度&GT受试者; 90 nmol / L的,并且没有在高浓度死亡率增加的证据,表明在人口平均浓度适度增加可能具有潜在的健康益处,但与LT; 1%的人口有浓度> 120 nmol / L的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号